UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
Form 6-K
 
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16
OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the month of August, 2015
 
Commission File Number 000-26495
 
CYREN Ltd.
(Translation of Registrant’s name into English)
 
1 Sapir Road, 5th Floor, Beit Ampa, P.O. Box 4014, Herzliya 46140, Israel
(Address of Principal Executive Offices)
 
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
 
Form 20-F x     Form 40-F o
 
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):___
 
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):___
 
 
 

 
 
On August 17, 2015, the Registrant issued a press release announcing its second quarter 2015 financial results for the period ending June 30, 2015.
 
A copy of the press release is annexed hereto as Exhibit 1 and incorporated herein by reference.
 
 
 

 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 
CYREN Ltd.
(Registrant)
 
       
Date: August 17, 2015
By: /s/ J. Michael Myshrall  
 
J. Michael Myshrall
 
 
Chief Financial Officer
 
       
 
 


 
 
 
 

 




Exhibit 1
 
 
 
PRESS RELEASE

CYREN Reports Second Quarter 2015 Results
and Provides Business Update Following Capital Raise
 
McLean, Va. – August 17, 2015 – CYREN (NASDAQ: CYRN) today announced its second quarter 2015 financial results for the period ending June 30, 2015, and provided a business update following its recent $12.6 million capital raise.

“As of today, we have an established foundation of users and reference customers, as well as a growing sales pipeline for our cloud-based CYREN WebSecurity (CWS) platform. We are already seeing the positive effects of this heightened brand awareness, as we are now attracting bigger, higher-quality RFPs and sales opportunities from potential customers,” stated Lior Samuelson, CEO and Chairman of the Board at CYREN.

He added: “We experienced an overwhelming response from our recent public offering, which was oversubscribed and validates that institutional investors believe in CYREN’s strategy and vision for cloud-based WebSecurity and Cyber Threat Protection.  The funding will help CYREN to accelerate R&D and hire additional sales professionals in order to address the demand generated by our newest product offerings.”

During the quarter, CYREN narrowed its GAAP net loss and cash burn, in part due to reduced operating expenses and additional items that positively impacted the quarterly run rate on a go forward basis.

Second Quarter 2015 Financial Highlights:
 
 
·
Revenues in accordance with U.S. Generally Accepted Accounting Principles (US GAAP) totaled $6.7 million for the second quarter of 2015, compared to $8.3 million for the second quarter of 2014 and $7.0 million for the first quarter of 2015.  The reduction in revenue was primarily due to the weakness of the Euro since June 2014 and customer agreements that were not renewed at the end of their terms.
 
 
·
Non-GAAP revenues totaled $6.8 million for the second quarter of 2015, compared to $8.3 million for the second quarter of 2014 and $7.0 million for the first quarter of 2015. The difference between non-GAAP and GAAP revenue is derived from the fact that deferred revenues consolidated from acquired companies are recorded based on fair value rather than book value for GAAP purposes.
 
 
 
 
 

 
 
 
 
·
 
R&D expense for the second quarter of 2015 declined to $1.8 million from $3.1 million for the same period last year. This decline is attributable to the net capitalization of some software development costs, a new R&D grant from the Office of the Chief Scientist at the Ministry of Economy of Israel, and appreciation of the U.S. dollar versus the Euro and Shekel.
 
 
·
GAAP net loss for the second quarter of 2015 was $0.6 million, compared to a loss of $2.0 million in the second quarter of 2014 and a loss of $1.7 million in the first quarter of 2015.
 
 
·
GAAP loss per basic and diluted share for the second quarter of 2015 was $0.02, compared to a loss of $0.08 for the second quarter of 2014.
 
 
·
Non-GAAP net loss for the second quarter of 2015 was $1.2 million, compared to a loss of $1.1 million for the second quarter of 2014 and a loss of $1.0 million in the first quarter of 2015.
 
 
·
Non-GAAP loss per basic and diluted share was $0.04 for the second quarters of both 2015 and 2014.
 
 
·
Cash provided by operating activities during the quarter was $0.3 million.
 
 
·
Cash as of June 30, 2015 was $7.9 million, compared to $8.5 million as of March 31, 2015. The cash position as of June 30, 2015 does not reflect the $11.5 million in net proceeds CYREN raised in a public offering that priced on August 12, 2015.
 
For information regarding the non-GAAP financial measures discussed in this release, please see "Use of Non-GAAP Financial Information" and "Reconciliation of Selected GAAP Measures to Non GAAP Measures."
 
Recent Business Highlights:
 
 
·
Integrated CYREN WebSecurity with the SPARK® platform from WiFi SPARK, a UK-based managed WiFi service provider, which operates over 100,000 access points across Europe. This integration utilizes CYREN‘s recently-launched DNS-based policy enforcement for CWS and further validates the market’s interest in this solution.
 
 
·
Launched the CYREN Next Generation Sandbox service, which uniquely harnesses the power of automated, multi-layered sandboxing capabilities that rely on global cyber intelligence, instead of traditional human analysis or reactive procedures initiated due to customer infection or attack.
 
 
·
Announced that Securepoint, a German-based provider of network access, network security and mail archiving solutions, has added three new layers of CYREN cybersecurity technologies alongside its existing use of CYREN Antispam and Antimalware.
 
 
·
Announced Cyveillance, a subsidiary of QinetiQ, has launched a phishing protection service for enterprise and government customers.  The service utilizes CYREN’s Phishing Intelligence feed, which is delivered real-time from the CYREN cloud as part of its Cyber Intelligence Suite.
 
 
·
Awarded a government grant of NIS 3.6 million (approximately $0.9 million) from the Office of the Chief Scientist (OCS) at the Ministry of Economy of Israel.
 
 
·
Completed a public stock offering, resulting in gross proceeds of $12.6 million, excluding fees and expenses. Total proceeds include sale of shares offered under the underwriter’s over-allotment option.
 
 
 
 
 

 
 
Financial Results Conference Call:

The Company has scheduled a conference call later today, August 17, 2015, at 10 a.m. Eastern Time (5 p.m. Israel Time) to discuss its second quarter 2015 results.

To participate, please call one of the following teleconferencing numbers by dialing in at least 10 minutes before the conference call commences. If you are unable to connect using the toll-free numbers, please try the international dial-in number.

US Dial-in Number:                               1-888-397-5352
Israel Dial-in Number:                          1-80-924-5906
International Dial-in Number:             1-719-325-2491

The call will be simultaneously webcast live on the investor relations section of CYREN's website at http://www.cyren.com/ir.html.

For those unable to listen to the live call, a webcast replay of the call will be available beginning the day after the call; the replay link can be found by visiting the investor relations section of CYREN's corporate website.

About CYREN
Founded in 1991, CYREN (NASDAQ and TASE: CYRN) is a long-time innovator in cyber intelligence, offering next generation Security as a Service solutions to enterprises and powering the security solutions of more than 200 of the world’s largest IT and security technology providers. Providing real-time detection of cyber-attacks in many of the largest networks, CYREN maintains the broadest and deepest real-time Internet threat database in the world. Every day, CYREN collects and analyzes 17 billion pieces of threat data to protect 600 million global users. Threat data is gathered and cyber intelligence disseminated through 500,000 global points of presence in 200 countries.  Visit www.cyren.com.

Blog: blog.cyren.com
Facebook: www.facebook.com/CyrenWeb
LinkedIn: www.linkedin.com/company/cyren
Twitter: twitter.com/CyrenInc or twitter.com/CYREN_IR

To download CYREN’s investor relations app please visit Apple’s App Store for the iPhone and iPad or Google Play for Android mobile devices.

Use of Non-GAAP Measures 

Non-GAAP financial measures consist of GAAP financial measures adjusted to exclude: stock-based compensation expenses, amortization of acquired intangible assets, executive termination costs, deferred taxes and deferred revenues related to acquisitions, one-time settlement agreements, reorganization expenses, adjustments to earn-out obligations and capitalization of technology. The purpose of such adjustments is to give an indication of the company's performance exclusive of non-cash charges and other items that are considered by management to be outside of the company's core operating results. The company's non-GAAP financial measures are not meant to be considered in isolation or as a substitute for comparable GAAP measures, and should be read only in conjunction with the company's consolidated financial statements prepared in accordance with GAAP.
 
 
 
 

 
 
 
Company management regularly uses supplemental non-GAAP financial measures internally to understand, manage and evaluate the business and make operating decisions.
 
These non-GAAP measures are among the primary factors management uses in planning for and forecasting future periods. The company believes this adjustment is useful to investors as a measure of the ongoing performance of the business. The company believes these non-GAAP financial measures provide consistent and comparable measures to help investors understand the company's current and future operating cash flow performance. These non-GAAP financial measures may differ materially from the non-GAAP financial measures used by other companies. Reconciliation between results on a GAAP and non-GAAP basis is provided in a table immediately following the Consolidated Statements of Income. The presentation of this non-GAAP financial information is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with GAAP. Management uses both GAAP and non-GAAP measures when evaluating the business internally and therefore felt it important to make these non-GAAP adjustments available to investors.
 
This press release may contain forward-looking statements, including projections about our business, within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. For example, statements in the future tense, and statements including words such as "expect," "plan," "estimate," "anticipate," or "believe" are forward-looking statements. These statements are based on information available to us at the time of the presentation; we assume no obligation to update any of them. The statements in this presentation are not guarantees of future performance and actual results could differ materially from our current expectations as a result of numerous factors, including business conditions and growth or deterioration in the Internet market, commerce and the general economy, both domestic as well as international; fewer than expected new-partner relationships; competitive factors, including pricing pressures; technological developments, and products offered by competitors; the ability of our OEM partners to successfully penetrate markets with products integrated with CYREN technology; a slower than expected acceptance rate for our newer product offerings; availability of qualified staff; and technological difficulties and resource constraints encountered in developing new products,  as well as those risks described in the text of this presentation and the company's Annual Reports on Form 20-F and reports on Form 6-K, which are available through www.sec.gov.

U.S. Investor Contact
Garth Russell
KCSA Strategic Communications
+1 212 896 1250
grussell@kcsa.com

Israel Investor Contact
Iris Lubitch
SmartTteam
+972 54 2528007
Iris@smartteam.co.il
 
 
 
 

 
 
 
Company Contact
Mike Myshrall, CFO
CYREN
+1 703 760 3320
mike.myshrall@CYREN.com
 
Media Contact
Matthew Zintel
Zintel Public Relations
+1 281 444 1590
matthew.zintel@zintelpr.com
 
 
 
 

 
 
 
CYREN LTD.
 
 CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in  thousands of U.S. dollars, except per share amounts)
 
   
Three months ended
   
Six months ended
 
   
June 30
   
June 30
 
 
 
2015
   
2014
   
2015
   
2014
 
   
Unaudited
   
Unaudited
   
Unaudited
   
Unaudited
 
                         
Revenues
  $ 6,726     $ 8,262     $ 13,719     $ 16,352  
                                 
Cost of revenues
    2,105       2,065       4,168       4,087  
                                 
Gross profit
    4,621       6,197       9,551       12,265  
                                 
Operating expenses:
                               
                                 
Research and development, net
    1,799       3,081       4,508       5,981  
                                 
Sales and marketing
    2,197       3,137       4,439       6,129  
                                 
General and administrative
    1,295       1,882       2,709       4,149  
                                 
Adjustment of earn-out obligation
    (75 )     -       (77 )     -  
                                 
Total operating expenses
    5,216       8,100       11,579       16,259  
                                 
Operating loss
    (595 )     (1,903 )     (2,028 )     (3,994 )
                                 
Other income
    4       -       4       200  
                                 
Financial expense, net
    (132 )     (167 )     (283 )     (463 )
                                 
Net loss before taxes
    (723 )     (2,070 )     (2,307 )     (4,257 )
                                 
Tax benefit (expense)
    75       75       (11 )     120  
                                 
Net loss
  $ (648 )   $ (1,995 )   $ (2,318 )   $ (4,137 )
                                 
Loss per share - basic
  $ (0.02 )   $ (0.08 )   $ (0.07 )   $ (0.16 )
                                 
Loss per share - diluted
  $ (0.02 )   $ (0.08 )   $ (0.07 )   $ (0.16 )
                                 
Weighted average number of shares outstanding:
                         
                           
Basic
    31,444       26,577       31,421       26,548  
                                 
Diluted
    31,444       26,577       31,421       26,548  
 
 
 
 

 
CYREN LTD.
 
RECONCILIATION OF SELECTED GAAP MEASURES TO NON-GAAP MEASURES
(in  thousands of U.S.dollars, except per share amounts)
 
   
Three months ended
   
Six months ended
 
   
June 30
   
June 30
 
 
 
2015
   
2014
   
2015
   
2014
 
   
Unaudited
   
Unaudited
   
Unaudited
   
Unaudited
 
                         
GAAP operating loss
  $ (595 )   $ (1,903 )   $ (2,028 )   $ (3,994 )
Stock-based compensation (1)
    270       357       533       661  
Amortization of intangible assets (2)
    383       467       768       891  
Adjustment to earn-out liabilities (3)
    (75 )     -       (77 )     -  
Executive terminations (5)
    -       69       -       208  
Adjustment to deferred revenues (6)
    42       52       85       104  
Settlement agreements (7)
    (628 )     -       (628 )     -  
Reorganization expenses (8)
    -       -       -       75  
Capitalization of technology (9)
    (505 )     -       (505 )     -  
                                 
Non-GAAP operating loss
  $ (1,108 )   $ (958 )   $ (1,852 )   $ (2,055 )
                                 
GAAP net loss
  $ (648 )   $ (1,995 )   $ (2,318 )   $ (4,137 )
Stock-based compensation (1)
    270       357       533       661  
Amortization of intangible assets (2)
    383       467       768       891  
Adjustment to earn-out liabilities (3)
    (52 )     96       (29 )     189  
Income taxes (4)
    (82 )     (113 )     (165 )     (214 )
Executive terminations (5)
    -       69       -       208  
Adjustment to deferred revenues (6)
    42       52       85       104  
Settlement agreements (7)
    (628 )     -       (628 )     (200 )
Reorganization expenses (8)
    -       -       -       75  
Capitalization of technology (9)
    (511 )     -       (511 )     -  
                                 
Non-GAAP net loss
  $ (1,226 )   $ (1,067 )   $ (2,265 )   $ (2,423 )
                                 
GAAP loss per share (diluted)
  $ (0.02 )   $ (0.08 )   $ (0.07 )   $ (0.16 )
Stock-based compensation (1)
    0.01       0.01       0.02       0.02  
Amortization of intangible assets (2)
    0.01       0.02       0.02       0.03  
Adjustment to earn-out liabilities (3)
    (0.00 )     0.00       (0.00 )     0.01  
Income taxes (4)
    (0.00 )     (0.00 )     (0.01 )     (0.01 )
Executive terminations (5)
    0.00       0.00       0.00       0.01  
Adjustment to deferred revenues (6)
    0.00       0.00       0.00       0.01  
Settlement agreements (7)
    (0.02 )     0.00       (0.02 )     (0.01 )
Reorganization expenses (8)
    0.00       0.00       0.00       0.00  
Capitalization of technology (9)
    (0.02 )     0.00       (0.01 )     0.00  
                                 
Non-GAAP loss per share (diluted)
  $ (0.04 )   $ (0.04 )   $ (0.07 )   $ (0.09 )
                                 
Numbers of shares used in computing non-GAAP loss per share (diluted)
    31,444       26,577       31,421       26,548  
                                 
(1) Stock-based compensation
                               
Cost of revenues
  $ 18     $ 13     $ 34     $ 25  
Research and development
    73       74       137       147  
Sales and marketing
    63       72       136       144  
General and administrative
    116       198       226       345  
                                 
    $ 270     $ 357     $ 533     $ 661  
(2) Amortization of intangible assets
                               
Cost of revenues
  $ 188     $ 235     $ 378     $ 432  
Research and development
    1       -       1       -  
Sales and marketing
    194       232       389       459  
                                 
    $ 383     $ 467     $ 768     $ 891  
(3) Adjustment to earn-out liabilities
                               
General and administrative
  $ (75 )   $ -     $ (77 )   $ -  
Financial expenses, net
    23       96       48       189  
                                 
    $ (52 )   $ 96     $ (29 )   $ 189  
(4) Income taxes
                               
Deferred tax asset - tax benefit
  $ (82 )   $ (113 )   $ (165 )   $ (214 )
                                 
    $ (82 )   $ (113 )   $ (165 )   $ (214 )
(5) Executive terminations
                               
General and administrative
  $ -     $ 69     $ -     $ 208  
                                 
    $ -     $ 69     $ -     $ 208  
(6) Adjustment to deferred revenues
                               
Revenues
  $ 42     $ 52     $ 85     $ 104  
                                 
    $ 42     $ 52     $ 85     $ 104  
(7) Settlement agreements
                               
General and administrative
  $ (628 )   $ -     $ (628 )   $ -  
Other income
    -       -       -       (200 )
                                 
    $ (628 )   $ -     $ (628 )   $ (200 )
                                 
(8) Reorganization expenses
                               
General and administrative
  $ -     $ -     $ -     $ 75  
                                 
    $ -     $ -     $ -     $ 75  
                                 
(9) Capitalization of technology
                               
Research and development
  $ (505 )   $ -     $ (505 )   $ -  
Financial expenses, net
    (6 )     -       (6 )     -  
                                 
    $ (511 )   $ -     $ (511 )   $ -  
 
 

 
 
 
CYREN LTD.
 
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands of U.S. dollars)
 
   
June 30
   
December 31
 
 
 
2015
   
2014
 
   
Unaudited
   
Audited
 
             
                 Assets
           
    Current Assets:
           
Cash and cash equivalents
  $ 7,870     $ 11,063  
Trade receivables, net
    3,595       4,444  
Prepaid expenses and other receivables
    2,084       1,019  
Total current assets
    13,549       16,526  
                 
Lease deposits
    76       70  
Deferred tax assets
    -       13  
Deferred issuance costs
    153       -  
Severance pay fund
    575       594  
Property and equipment, net
    2,151       2,401  
Goodwill and intangible assets, net
    30,000       31,869  
Total long-term assets
    32,955       34,947  
Total assets
  $ 46,504     $ 51,473  
                 
Liabilities and Shareholders’ Equity
         
    Current Liabilities:
               
Credit line
  $ 4,492     $ 4,900  
Trade payables
    755       646  
Employees and payroll accruals
    2,082       2,359  
Deferred tax liability
    117       120  
Accrued expenses and other liabilities
    912       1,394  
Earn-out consideration
    2,868       2,269  
Deferred revenues
    3,187       4,097  
Total current liabilities
    14,413       15,785  
                 
Deferred revenues
    1,365       1,042  
Deferred tax liability
    1,688       1,984  
Earn-out consideration
    -       837  
Accrued severance pay
    690       666  
Other liabilities
    92       100  
Total long-term liabilities
    3,835       4,629  
                 
Shareholders’ equity
    28,256       31,059  
Total liabilities and shareholders’ equity
  $ 46,504     $ 51,473  
 
 
 

 
 
CYREN LTD.
 
 CONDENSED CONSOLIDATED CASH FLOW DATA
(in thousands of U.S. dollars)
 
   
Three months ended
   
Six months ended
 
   
June 30
   
June 30
 
   
2015
   
2014
   
2015
   
2014
 
Cash flows from operating activities:
 
Unaudited
   
Unaudited
   
Unaudited
   
Unaudited
 
                         
Net loss
  $ (648 )   $ (1,995 )   $ (2,318 )   $ (4,137 )
                                 
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
                               
Depreciation
    329       321       649       642  
Stock-based compensation
    270       357       533       661  
Amortization of intangible assets
    383       467       768       891  
Accrued interest, accretion of discount and exchange rate differences on credit line
    22       4       65       56  
Accretion and change in fair value of earn-out consideration, net
    (52 )     96       (29 )     189  
                                 
Changes in assets and liabilities:
                               
Trade receivables
    183       1,099       943       358  
Deferred taxes
    (80 )     (18 )     (124 )     (119 )
Prepaid expenses and other receivables
    (312 )     310       (1,089 )     535  
Trade payables
    (83 )     (426 )     96       (258 )
Change in long-term lease deposits
    (6 )     (7 )     (8 )     (5 )
Employees and payroll accruals, accrued expenses and other liabilities
    48       718       (692 )     (498 )
Deferred revenues
    173       (612 )     (607 )     (410 )
Accrued severance pay, net
    24       3       42       27  
Net cash provided by (used in) operating activities
    251       317       (1,771 )     (2,068 )
                                 
Cash flows from investing activities:
                               
                                 
Capitalization of technology, net of grants received
    (511 )     -       (511 )     -  
Purchase of property and equipment
    (227 )     (212 )     (401 )     (558 )
Net cash used in investing activities
    (738 )     (212 )     (912 )     (558 )
                                 
Cash flows from financing activities:
                               
                                 
Proceeds from bank loans and credit lines
    -       1,000       4,400       2,000  
Repayment of bank loans
    (73 )     -       (4,873 )     -  
Deferred issuance costs
    (153 )     -       (153 )     -  
Payment of earn-out consideration
    -       (351 )     -       (351 )
Proceeds from options exercised
    84       33       153       328  
Net cash provided by (used in) financing activities
    (142 )     682       (473 )     1,977  
Effect of exchange rate changes on cash and cash equivalents
    10       (10 )     (37 )     (4 )
Increase (decrease) in cash and cash equivalents
    (619 )     777       (3,193 )     (653 )
Cash and cash equivalents at the beginning of the period
    8,489       2,327       11,063       3,757  
Cash and cash equivalents at the end of the period
  $ 7,870     $ 3,104     $ 7,870     $ 3,104  
 
 


CYREN (NASDAQ:CYRN)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more CYREN Charts.
CYREN (NASDAQ:CYRN)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more CYREN Charts.